Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.
Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B; GuidAge study GROUP. Andrieu S, et al. Among authors: vellas b. Curr Alzheimer Res. 2008 Aug;5(4):406-15. doi: 10.2174/156720508785132271. Curr Alzheimer Res. 2008. PMID: 18690838 Clinical Trial.
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.
Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, Hochberg MC, Ferrari SL, Blain H, Binder EF, Rolland Y, Poiraudeau S, Benson CT, Myers SL, Hu L, Ahmad QI, Pacuch KR, Gomez EV, Benichou O; STEADY Group. Becker C, et al. Lancet Diabetes Endocrinol. 2015 Dec;3(12):948-57. doi: 10.1016/S2213-8587(15)00298-3. Epub 2015 Oct 27. Lancet Diabetes Endocrinol. 2015. PMID: 26516121 Clinical Trial.
Integrative Multimodal Metabolomics to Early Predict Cognitive Decline Among Amyloid Positive Community-Dwelling Older Adults.
Tremblay-Franco M, Canlet C, Carriere A, Nakhle J, Galinier A, Portais JC, Yart A, Dray C, Lu WH, Bertrand Michel J, Guyonnet S, Rolland Y, Vellas B, Delrieu J, Barreto PS, Pénicaud L, Casteilla L, Ader I; MAPT/DSA Group. Tremblay-Franco M, et al. Among authors: vellas b. J Gerontol A Biol Sci Med Sci. 2024 May 1;79(5):glae077. doi: 10.1093/gerona/glae077. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38452244 Free PMC article.
Patient-reported outcomes in sarcopenia: An ICFSR task force report.
Beaudart C, Cella D, Fielding RA, Rolland Y, Vellas B, Canevelli M; ICSFR Task Force. Beaudart C, et al. Among authors: vellas b. J Frailty Aging. 2025 Feb;14(1):100010. doi: 10.1016/j.tjfa.2024.100010. Epub 2025 Jan 1. J Frailty Aging. 2025. PMID: 39855889 Free article. Review.
Sex-specific associations of neurodegeneration and inflammatory biomarkers with intrinsic capacity in older adults: Findings from the 4-year longitudinal Multidomain Alzheimer's Prevention Trial (MAPT).
de Assunção Cortez Corrêa LC, Raffin J, Vellas B, Guerra RO, de Souto Barreto P. de Assunção Cortez Corrêa LC, et al. Among authors: vellas b. Maturitas. 2025 Feb;193:108191. doi: 10.1016/j.maturitas.2024.108191. Epub 2025 Jan 3. Maturitas. 2025. PMID: 39754932 Clinical Trial.
Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR).
Izquierdo M, de Souto Barreto P, Arai H, Bischoff-Ferrari HA, Cadore EL, Cesari M, Chen LK, Coen PM, Courneya KS, Duque G, Ferrucci L, Fielding RA, García-Hermoso A, Gutiérrez-Robledo LM, Harridge SDR, Kirk B, Kritchevsky S, Landi F, Lazarus N, Liu-Ambrose T, Marzetti E, Merchant RA, Morley JE, Pitkälä KH, Ramírez-Vélez R, Rodriguez-Mañas L, Rolland Y, Ruiz JG, Sáez de Asteasu ML, Villareal DT, Waters DL, Won Won C, Vellas B, Fiatarone Singh MA. Izquierdo M, et al. Among authors: vellas b. J Nutr Health Aging. 2025 Jan;29(1):100401. doi: 10.1016/j.jnha.2024.100401. Epub 2025 Jan 1. J Nutr Health Aging. 2025. PMID: 39743381 Free article. Review.
1,140 results